TIAP Success Story: ImmunoBiochem Targets a New Era of Precision Immunology
ImmunoBiochem Targets a New Era of Precision Immunology University of Toronto spin-off ImmunoBiochem is building a new class of precision medicines with an ambitious goal: selectively shut down the immune…
